News Releases
June 19, 2020
When a research project over 15 years in the making resulted in a drug that improved pulmonary function and oxygen delivery, researcher James D. Reynolds thought the drug could also help COVID-19 patients with severely compromised lung and heart function. Reynolds, Professor of Anesthesiology &…
June 10, 2020
A team led by Case Western Reserve University School of Medicine researchers has made two major discoveries involving psoriasis, a chronic and debilitating skin disease with no known cure. The researchers found that an overabundance of a protein known as KLK6 can produce and worsen the skin…
June 10, 2020
The Case Western Reserve University School of Medicine asserts that racism is a health pandemic. For many years, the Case Western Reserve University School of Medicine has worked to reduce health disparities and advance the health and inclusion of all races in our school, university, our city, and…
June 03, 2020
Haima Therapeutics has executed an exclusive license agreement with Case Western Reserve University to research, develop and market artificial platelet technologies to treat patients with various bleeding disorders. The core technologies were developed in the laboratory of Professor Anirban Sen…
May 26, 2020
Researchers have harnessed the power of electronic health records to gain insight into the potential of inflammation-controlling medications to reduce a patient’s Alzheimer’s disease risk. Rong Xu, professor of biomedical informatics and director of the Center for Artificial Intelligence in Drug…
May 15, 2020
Medicine’s Paul Tesar receives J. Bruce Jackson, MD, Award for Excellence in Undergraduate Mentoring
No content available.
May 15, 2020
No content available.
May 15, 2020
No content available.
May 07, 2020
The Case Western Reserve University COVID-19 Task Force, led by Jonathan Karn and Rafick Pierre Sekaly, has made great progress over the past seven weeks. Bringing forward the best ideas and expertise from CWRU and its affiliates, the task force is producing energetic and thoughtful collaboration…
April 23, 2020
The National Heart, Lung, and Blood Institute (NHLBI) has awarded Case Western Reserve University up to $3.7 million to assess emerging genome editing-based therapies being tested for curing sickle cell disease (SCD) at leading U.S research universities and hospitals. SCD is the most well-known…